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ABSTRACT 
 
A Simple, accurate and precise method was developed and validated for the determination of flucloxacillin 
sodium in its tablet dosage form. The separation was eluted on xterra c18 column (4.6x150mm, 5micron) 
using a mixture of octane buffer and methanol as mobile phase in a ratio of (30:70) which was pumped 
through column at a flow rate of 1ml/min. Optimised wavelength for flucloxacillin was 237nm, the retention 
time was 2.305minutes and the percentage purity was found to be 98.14%. System suitability parameters 
such as theoretical plate and tailing factor for flucloxacillin sodium was found to be 2991.64 and 1.90 re-
spectively, the proposed method was validated as per ICH guidelines (ICH, Q2 AND (R1)) the method was 
found to be linear at the concentration range of 20-100µg/ml and the correlation coefficient (r2) value was 
found to be 0.9994 percentage RSD for precision was 0.9% and percentage RSD for ruggedness was 0.5%. 
The precision study was precise, robust and repeatable. The LOD and LOQ values are 2.98 and 9.98 respec-
tively. Hence the suggested RP-HPLC method can be used for routine analysis for flucloxacillin sodium in 
tablet dosage form. 
Keywords: RP-HPLC; Xterra C18 column; Flucloxacillin sodium; system suitability parameters; ICH guide-
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INTRODUCTION 
Flucloxacillin sodium is chemically known as so-
dium;(2S,5R,6R)-6-((3-(2-Chloro-6-fluorophenyl)-5-
methyl-1,2-oxazole-4-carbonyl)amino)-3,3-dime-
thyl-7-oxo-4-thia-1-azabicyclo (3.2.0)heptanes-2-
carboxylate. It is an ßeta lactum antibiotic and it is 
used to treat skin infection, wound infections, chest 
infections and ear infections in children.  
The literature review shows very few methods for 
flucloxacillin sodium estimation by Rp-Hplc method. 
Hence it felt that, there is need of development of 
new, precise and cost effective analytical method de-
velopment for the estimation of flucloxacillin sodium 
in a tablet dosage form. 
 
Figure 1: Structure of Flucloxacillin sodium 
Present work is aimed to develop a new, simple, fast, 
rapid, accurate, cost effective, and reproducible 
method for the analysis of flucloxacillin sodium. The 
developed method was validated according to the ICH 
guidelines and degradation studies were performed.  
MATERIALS AND METHODS 
Chemicals used 
Octane buffer, Water, Acetonitrile & methanol, So-
dium hydroxide, Potassium di hydrogen ortho phos-
phate, Ortho phosphoric acid all chemicals where 
used HPLC grade only manufactured by Qualigens. 
All the glassware’s were used of borosilicate glass of 
class-A and all the solvents and prepared solutions 
were filtered through nylon filter 0.45µm. 
Table 1: Instrument specification 
S.NO Instrument Model/Company 
1. HPLC 
WATERS Model:2965 with 2478 
detector-Empower 2 software 
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2. 
Ultra-soni-
cator 
SE60US/SCALETEC 
3. 
Electronic bal-
ance 
SAB224CL/ENERTECH 
4. Thermal oven YAMTO 
5. pH meter PH-7000/SMIS 
6. 
Filter paper 
0.45 microns 
MILLI PORE 
7. 
UV/VIS spec-
trophotometer 
LABINIDA UV 3000+ 
8. 
Pipettes and 
burettes 
Borosil 
Details of marketed formulations 
Label claim: Flucloxacillin sodium 500mg, Brand 
name: Staphonex-500mg tablet 
Details of procured drugs 
Flucloxacillin sodium was procured from Fortune 
pharma training institute, Hyderabad, India. It is used 
as standard drug it showed 98.14% of assay results. 
Wave length selection 
UV Spectrum of 10µg/ml for flucloxacillin sodium in 
diluents (mobile phase composition) was recorded 
by scanning in the range of 200nm to 400nm. From 
the UV spectrum wavelength selected as 237nm. At 
this wavelength flucloxacillin sodium shows good ab-
sorbance.  
 
Figure 2: UV Spectrophotometry of flucloxacillin so-
dium 
The chromatographic method development for the 
stimulation and estimation of flucloxacillin sodium 
were optimised in several trails for various parame-
ters as different column, flow rate and mobile phase, 
finally the chromatographic method was selected for 
the separation and quantification of flucloxacillin so-
dium in tablet dosage form by RP-HPLC method.  
Optimised chromatographic conditions 
Temperature : Ambient (25ºc) 
Modes of separation : Isocratic mode 
Column : X terra C18 4.68x150mm, 5micron 
Column temperature : Room temperature 
Flow rate : 1.0ml/min 
Injection volume : 20µl/min 
Wavelength : 237nm 
Run time : 10min 
Mobile phase : Octane buffer: methanol (30:70)  
Diluents : Mobile phase is used as diluents  
Standard preparation 
Accurately weigh and transfer 10mg of flucloxacillin 
sodium working standard into a 10ml clean dry volu-
metric flask add diluents and sonicate to dissolve it 
completely and make up the volume to the mark with 
the diluents. (Stock solution) 
Further pipette out 0.6 ml of flucloxacillin sodium of 
the above stock solution into a 10ml volumetric flask 
and dilute up to the mark with diluents. (60ppm) 
Preparation of 0.1% octa sulphonic acid: (octane 
buffer)  
 To prepare 0.1% octa sulphonic acid, pipette out 1 ml 
octa sulphonic acid in 1000ml water. Adjust the pH 
up to 3.5 with sodium hydroxide solution. 
Preparation of mobile phase 
Mix a mixture of buffer 300ml (30%) and 700ml ace-
tonitrile HPLC (70%) and degas in ultrasonic water 
bath for 5 minutes. Filter through 0.45µm filter under 
vacuum filtration. 
Diluents preparation: Mobile phase is used as dilu-
ents.  
 
Figure 3: chromatogram of optimized flucloxacillin so-
dium 
Assay 
Standard and sample solutions are injected as de-
scribed under experimental condition. The corre-
sponding results are shown below.  
𝐴𝑇
𝐴𝑆
×
𝑊𝑆
𝐷𝑇
×
𝐷𝑇
𝑊𝑇
×
𝑃
100
×
𝐴𝑣𝑔.𝑊𝑡
𝐿𝐶
× 100 
Where: 
AT = Average area counts of test preparation, AS = Av-
erage area counts of standard preparation, WS = 
Weight of working standard taken in mg, P = Percent-
age purity of working standard, LC = Label claim of 
flucloxacillin sodium mg/ml (60mg) 
RESULTS AND DISCUSSION 
Method development 
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A reverse phase HPLC method was developed by con-
sidering the system suitability parameters i.e. resolu-
tion between the peaks, tailing factor (T), number of 
theoretical plates (N), run time and cost effectiveness. 
The optimised method developed resulted in the elu-
tion of flucloxacillin sodium at 2.305 and the total run 
time will be 10minutes with all the system suitability 
parameters. 
System suitability results for flucloxacillin sodium 
was found at RT 2.305 with peak area of 1723973 
Theoretical plates 2933.35 and Tailing/fronting fac-
tor 1.93. 
The acceptance criteria for the tailing factor should 
be not more than 2.0 and for the theoretical plates 
should be not less than 2000  
 
Figure 4: Chromatogram of blank 
 
Figure 5: Chromatogram of standard 
Method validation 
Validation is a process that establishes by laboratory 
studies in which the performance characteristics of 
method meet the requirements for the intended ana-
lytical application. The RP-HPLC method developed 
was validated according to the ICH guidelines. The 
method was validated for the parameters in terms of 
system suitability, selectivity, linearity, accuracy, pre-
cision, ruggedness, robustness, and limit of detection 
(LOD), limit of quantification (LOQ). 
Specificity 
Specificity is carried out to determine whether there 
is any interference of any impurities in retention time 
of analytical peak. The study was performed by in-
jecting blank and standard into the system. There is 
no inference of any peak in blank with the retention 
time of the analytical peaks. 
 
Figure 6: Chromatogram of sample 
The specificity test was performed and there were no 
inference of impurities in the retention time of ana-
lytical peak. 
Linearity 
The linearity study was performed from the concen-
tration of 20µg/ml to 100µg/ml. Each concentration 
was injected into chromatographic system. The area 
of each level was used for the calculation of correla-
tion coefficient factor. The results are tabulated in ta-
ble 2 
Table 2: Linearity results for Flucloxacillin sodium 
S.no Linearity level Concentration Area 
1. Ⅰ 20 76965 
2. Ⅱ 40 152413 
3. Ⅲ 60 218596 
4. Ⅳ 80 298643 
5. Ⅴ 100 364351 
Fig: 6 Linearity graph of Flucloxacillin sodium 
 
Figure 7: Linearity graph of Flucloxacillin sodium 
The linearity study was performed from the concen-
tration range of 20µg/ml to 100µg/ml and the corre-
lation coefficient was found to be 0.9994.  
Accuracy  
The accuracy study was performed for 50%, 100% 
and 150% for flucloxacillin sodium and each level 
were injected into the chromatographic system. The 
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area of each level was used for the calculation of %re-
covery, the results are tabulated in table 3. 
Table 3: Accuracy results for flucloxacillin sodium 
% Concentration 
(At specification level) 
Area 
Amount 
Added 
(mg) 
Amount 
Found 
(mg) 
% 
recovery 
Mean 
recovery 
50% 801981.5 5 4.86 96.52  
 
99.95 
100% 913613.7 12.5 12.49 99.92 
150% 13478454.7 18.75 18.85 100.53 
Precision 
Repeatability: The precision study was performed 
for five injections of flucloxacillin sodium. Each stand-
ard injection was injected into chromatographic sys-
tem. The each area of standard injection is used for 
the calculation of %RSD. The results are tabulated in 
table 4. 
Table 4: summarized precision results for flucloxacillin 
sodium 
Injection 
RT (Flucloxacil-
lin sodium) 
Area of flucloxacil-
lin sodium 
Injection-1 2.299 1693252 
Injection-2 2.300 1718953 
Injection-3 2.301 1721186 
Injection-4 2.301 1725670 
Injection-5 2.301 17133700 
Average  1718552.4 
Standard de-
viation 
 15226.1 
%RSD  0.9 
 
Figure 8: Precision overlay chromatogram 
The %RSD for the area of five standard results should 
not be more than 2  
Intermediate precision 
The standard solution was injected for five times and 
the area is measured for all the five injections in 
HPLC.  
Table 5: summarized ID precision results for flucloxa-
cillin sodium 
Injection 
RT (Flucloxacil-
lin sodium) 
Area for flucloxacil-
lin sodium 
Injection-1 2.295 1707855 
Injection-2 2.298 1722965 
Injection-3 2.299 1715296 
Injection-4 2.300 1729458 
Injection-5 2.300 1718752 
Average  1718805.3 
Standard de-
viation 
 8010.9 
%RSD  0.5 
The %RSD for the area of five injections should not be 
more than 2.0%. 
LOD (Detection of limit) 
The detection of limit of flucloxacillin sodium was 
found to be 2.98, Acceptance criteria: S/N ratio value 
shall be 3 for LOD solution. 
LOQ (Limit of quantification) 
The quantification limit of flucloxacillin sodium is 
9.98. Acceptance criteria: S/N ratio value shall be 10 
for LOQ solution 
Robustness 
As a part of robustness, deliberate change in the flow 
rate, mobile phase composition, temperature, varia-
tion was made to evaluate the impact on the method. 
The flow rate was varied at 0.9ml/min to 
1.1ml/min: Standard solution 60ppm of flucloxacil-
lin sodium prepared and analysed using the varied 
flow rates along with method flow rate. 
On the evaluation of the above results, it can be con-
cluded that the variation in flow rate affected the 
method significantly, Hence it indicates that the 
method robust even by change in flow rate ±10%. The 
method is robust only in less flow condition. 
Table 6: System suitability results for flucloxacillin so-
dium 
S.no 
Flow 
rate 
(ml/min) 
System suitability results 
Retention 
time 
USP plate 
count 
USP 
Tailing 
1 0.9ml/min 2.473 3140 1.9 
2 1.0ml/min 2.305 2997 1.94 
3 1.1ml/min 1.835 3115 1.8 
The Organic composition in the mobile phase was 
varied ±10% 
Standard solution 60µg/ml of flucloxacillin sodium 
was prepared and analysed using the varied mobile 
phase composition along with actual mobile phase 
composition in the method. 
The results are summarized  
On the evaluation of above results, it can be con-
cluded that the variation in 10% organic composition 
in the mobile phase affected the method significantly. 
Hence it indicates that the method is robust even by 
change in mobile phase ±10%. 
Table 7: change in organic phase results for flucloxa-
cillin sodium 
S.no System suitability parameters 
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Change in 
the 
Organic 
composition 
In mobile 
phase 
Reten-
tion time 
USP Plate 
count 
USP 
Tailing 
1. 10% less 2.398 3321 1.9 
2. *Actual 2.305 2997 1.94 
3. 10% more 1.828 3315 1.8 
Forced degradation studies 
Accurately weigh and transfer 10mg of flucloxacillin 
sodium working standard into a 10ml clean dry volu-
metric flask add diluents and sonicate to dissolve it 
completely and make up the volume up to the mark 
with stock solution. 
Hydrolytic degradation under acidic condition 
Pipette 0.6ml of flucloxacillin sodium of the above 
stock solution into a 10ml volumetric flask added 
about 3 ml of 0.1N Hcl and sonicated for 10minutes 
and kept it in darkness for 12 hours then refluxed un-
der heat at 60ºc in heating mantle for 1 hour. Neutral-
ize the sample solution using 0.1N NaoH and diluted 
up to the mark with diluents. The final sample was fil-
tered through 0.44 micron injection filters and in-
jected into HPLC system. 
Hydrolytic degradation under alkaline condition 
Pipette 0.6ml of flucloxacillin sodium of the above 
stock solution into a 10ml volumetric flask add about 
3ml of 0.1N NaoH and sonicated for 10minutes and 
kept it in darkness for 12hours then refluxed under 
heat at 60ºc in a heating mantle for 1 hour. Neutralize 
the sample solution using 0.1N Hcl and diluted up to 
the mark with diluents. The final sample was filtered 
through 0.44  micron injection filters and injected 
into HPLC system. 
Thermal degradation 
Pipette 0.6ml of flucloxacillin sodium of the above 
stock solution into a 10ml volumetric flask and kept 
in oven under heat at 105ºc for 12 hours and diluted 
up to the mark with diluents. The final sample was fil-
tered through 0.44 micron injection filters and in-
jected into HPLC system  
Peroxide degradation 
Pipette 0.6ml of flucloxacillin sodium of the above 
stock solution into a 10ml volumetric flask added 3ml 
of 3% hydrogen peroxide (H2O2) and sonicated for 
10minutes and kept in darkness for 12hours and re-
fluxed under heat at 60ºc in a heating mantle for 1 
hour. The final sample was filtered through 0.44 mi-
cron injection filters and injected into HPLC system. 
Photo degradation 
Pipette 0.6ml above stock solution into a 10ml volu-
metric flask and expose to sunlight for 24hours and 
the volume was made up to mark with the diluents. 
Filter the solution with 0.45 microns syringe filters 
and place in vials. 
Table 8: Degradation results of flucloxacillin sodium 
 
Flucloxacillin sodium 
Area %Degraded 
Standard 1720758  
Acid 1626465 5.479736 
Base 1649322 4.151426 
Peroxide 1651577 4.020379 
Thermal 1668536 3.034825 
Photo 1551478 9.837525 
Table 9: Summarized results of method validation 
Parameters 
Flucloxacillin so-
dium 
Limit 
Linearity range 
(µg/ml) 
0-1000µg/ml R²˂1 
Regression coefficient 
(R²) 
0.999 R²˂1 
Regression equation 
(Y=mx+c) 
Y=3647x + 2800.5 
R²=0.9994 
R²˂1 
Assay 98.12% 90-100% 
Specificity Specific 
No infer-
ence 
Precision 0.9 NMT 2.0% 
Intermediate precision 
(%RSD) 
0.5 NMT 2.0% 
Accuracy 
(% recovery) 
99.95% 98-102% 
LOD 2.98 NMT 3 
LOQ 9.98 NMT 10 
CONCLUSION 
From the above experimental results and parameters 
it was concluded that, A new method as established 
for flucloxacillin sodium by RP-HPLC method. The 
chromatographic conditions were successfully devel-
oped and results are given below for the separation 
of flucloxacillin sodium by using Xterra C18 
4.6x150mm, 5micron, flow rate was 1.0ml/min, mo-
bile phase was octane buffer: methanol (30:70) 
The proposed method was found to be simple, spe-
cific, precise, accurate, rapid and economical for the 
determination of flucloxacillin sodium in pharmaceu-
tical dosage form. The developed method was vali-
dated in terms of accuracy, precision, linearity, ro-
bustness and ruggedness. The results will be vali-
dated statistically according to the ICH guidelines. 
The simple recoveries in all the formulations were in 
good agreement with their respective label claims. 
Hence the suggested RP-HPLC method can be used 
for routine analysis of flucloxacillin sodium in API 
and pharmaceutical dosage form.  
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